SUZANNE WARPULA: Open Payments
NPI 1093201584 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$248 in 13 payments from 7 companies in 2025. Trend: 2023 $1,418 · 2024 $124 · 2025 $248
Food & beverage: $248
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $95 |
| PFIZER INC. | 3 | $45 |
| Novo Nordisk Inc | 2 | $38 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Lilly USA, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: VRAYLAR, ELIQUIS, QULIPTA, TRELEGY ELLIPTA, Rybelsus, JARDIANCE, TRINTELLIX, Wegovy.
Industry payments across NC — which companies pay providers there.
